mitomycin intravesical solution
Zusduri Approved for Recurrent Low-Grade Intermediate-Risk Non–Muscle-Invasive Bladder Cancer
The FDA has approved Zusduri for adult patients with recurrent low-grade intermediate-risk ...
JUNE 14, 2025

Load more